Like RPS11, RPS20 is one of the RPs that can also bind to MDM2 and activate p53 [59] and it was reported that overexpression of RPS20 is associated with an adverse outcome in medulloblastoma [60]. This evidence concerns the gene MDM2 and medulloblastoma.